News - Astellas Pharma, Rare diseases

Filter

Popular Filters

Astellas in-licenses antibody from Evec; Mitsubishi Tanabe deal with Synageva

06-09-2011

Japanese biotech firm Evec has entered a license agreement for one of its fully-human antibodies against…

Asia-PacificAstellas PharmaBiotechnologyEvecImmunologicalsLicensingMitsubishi TanabePharmaceuticalRare diseasesResearchSynageva BioPharma

Back to top